The value of animal models for drug development in multiple sclerosis.

Brain : a Journal of Neurology
Manuel A FrieseLars Fugger

Abstract

The rodent model for multiple sclerosis, experimental allergic (autoimmune) encephalomyelitis (EAE), has been used to dissect molecular mechanisms of the autoimmune inflammatory response, and hence to devise and test new therapies for multiple sclerosis. Clearly, artificial immunization against myelin may not necessarily reproduce all the pathogenetic mechanisms operating in the human disease, but most therapies tested in multiple sclerosis patients are nevertheless based on concepts derived from studies in EAE. Unfortunately, several treatments, though successful in pre-clinical EAE trials, were either less effective in patients, worsened disease or caused unexpected, severe adverse events, as we review here. These discrepancies must, at least in part, be due to genetic and environmental differences, but the precise underlying reasons are not yet clear. Our understanding of EAE pathogenesis is still incomplete and so, therefore, are any implications for drug development in these models. Here, we suggest some potential explanations based on new thinking about key pathogenic concepts and differences that may limit extrapolation from EAE to multiple sclerosis. To try to circumvent these rodent-human dissimilarities more systemati...Continue Reading

Citations

Jun 21, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Samuel W Hall, Anne Cooke
Sep 19, 2009·Acta Neuropathologica·Markus KippCordian Beyer
Oct 15, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Yolanda S KapBert A 't Hart
Jan 17, 2012·Journal of Agricultural and Food Chemistry·Junping XinSusan O McGuire
May 16, 2009·Nature Reviews. Immunology·Lars FuggerJohn I Bell
Jan 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Enrico CristanteEgle Solito
Dec 4, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Robert NisticòDiego Centonze
Aug 22, 2007·Neuroimmunomodulation·Stefan M Gold, Christoph Heesen
Nov 17, 2009·Journal of Neuroinflammation·Nikolaos PaschalidisFulvio D'Acquisto
Dec 19, 2008·Disease Models & Mechanisms·Clare E BuckleyRobin J M Franklin
May 25, 2007·CNS Drugs·Bernd C Kieseier, Heinz Wiendl
Nov 13, 2008·CNS Drugs·Fabio FumagalliMarco Andrea Riva
Jul 14, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jochen C UlzheimerHeinz Wiendl
Aug 28, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sven G MeuthHeinz Wiendl
Mar 28, 2013·International Journal of Medical Sciences·Yu Lin, Liang Wen
Mar 19, 2014·Nature Reviews. Neurology·Manuel A FrieseLars Fugger
Apr 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Michael ForteDennis Bourdette
May 4, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Morad ZayoudFlorian C Kurschus
Aug 13, 2015·Multiple Sclerosis and Related Disorders·David Baker, Sandra Amor
Apr 27, 2011·Current Opinion in Neurology·Andrew R Pachner
Jan 1, 2008·Expert Opinion on Drug Discovery·Ha JinnahEllen J Hess
May 29, 2013·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Abolfazl Azami TamehHomayoun Naderian
Nov 14, 2012·Psychoneuroendocrinology·Anders KlingSolbritt Rantapää-Dahlqvist
Jun 17, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ester CantóManuel Comabella
May 22, 2009·Journal of Neuropathology and Experimental Neurology·Samuel J JacksonIan D Duncan
Jan 22, 2011·Trends in Molecular Medicine·Bert A 't HartRobert Weissert
Mar 2, 2010·Journal of the Neurological Sciences·Bijal K Mehta
Aug 30, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Alan RegenbergRichard J Traystman
Dec 15, 2015·Journal of Endocrinological Investigation·X Huang, Z Yang
Aug 19, 2008·Progress in Histochemistry and Cytochemistry·Iris KulbatskiCharles H Tator
Jan 10, 2008·Trends in Immunology·Ruth HuizingaSandra Amor
Oct 30, 2007·Journal of the Neurological Sciences·Tamara GlaserOliver Brüstle
Apr 1, 2015·European Journal of Pharmacology·Melanie L Graham, Mark J Prescott
Apr 29, 2009·Annals of Neurology·Joseph R Berger, Sidney Houff
May 22, 2007·Developmental Neurobiology·Jeffrey I Greenstein
Mar 1, 2012·Annals of Neurology·Natalia Manrique-HoyosDoron Merkler
Apr 15, 2011·Immunological Reviews·Joan M Goverman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.